Vaccine effectiveness of 99.3 per cent has been seen in individuals fully inoculated against Covid as per the data uploaded on India Covid-19 Tracker till January 2, the Parliament was told on Friday.
The Indian Council of Medical Research (ICMR) has developed the India Covid-19 Vaccine Tracker, by merging mainly three national databases -- CoWIN, National Covid-19 Testing database and Covid-19 India portal, Health Minister Mansukh Mandaviya told the Lok Sabha in a written reply.
"The latest data analysed and uploaded till January 2, 2022 depicts vaccine effectiveness of 99.3 per cent in fully vaccinated individuals against Covid-19," he said, adding that the tracker is updated periodically and displays the effectiveness of partial and full vaccination against Covid-19.
He said that the Omicron variant is the dominant variant in the country presently. Whole genome sequencing for Omicron variant is done for all RTPCR positive samples from international travellers arriving since November 28, 2021.
Stressing that the Centre is supporting states in their endeavour to manage Covid-19 since the beginning of the pandemic, Mandaviya said that given the emergence of mutated variants with variable impact on transmissibility, virulence and effectiveness of vaccines, the likelihood of resurgence of Covid-19 trajectory in the country is monitored by various expert committees under ICMR, DGHS and other departments.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)